DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs
Cell · 2023-06 · 186 (13) · 2765-2782.e28
DOI: 10.1016/j.cell.2023.05.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2023-06. Verfasst von Hongshan Guo und 21 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20…. Hauptthemen laut MEDLINE: DNA Methylation, Prostatic Neoplasms. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
- Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
- Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
- Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
- Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
Förderung
- NCI NIH HHS
- NIBIB NIH HHS
- Howard Hughes Medical Institute
Zitieren
APA
Guo, H., Vuille, J. A., Wittner, B. S., Lachtara, E. M., Hou, Y., Lin, M., Zhao, T., Raman, A. T., Russell, H. C., Reeves, B. A., Pleskow, H. M., Wu, C. L., Gnirke, A., Meissner, A., Efstathiou, J. A., Lee, R. J., Toner, M., Aryee, M. J., Lawrence, M. S., …, & Haber, D. A. (2023). DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs. Cell, 186(13), 2765-2782.e28. https://doi.org/10.1016/j.cell.2023.05.028
Vancouver
Guo H, Vuille JA, Wittner BS, Lachtara EM, Hou Y, Lin M, et al. DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs. Cell. 2023;186(13):2765-2782.e28. doi:10.1016/j.cell.2023.05.028
BibTeX
@article{Guo2023,
author = {Guo, Hongshan and Vuille, Joanna A and Wittner, Ben S and Lachtara, Emily M and Hou, Yu and Lin, Maoxuan and Zhao, Ting and Raman, Ayush T and Russell, Hunter C and Reeves, Brittany A and Pleskow, Haley M and Wu, Chin-Lee and Gnirke, Andreas and Meissner, Alexander and Efstathiou, Jason A and Lee, Richard J and Toner, Mehmet and Aryee, Martin J and Lawrence, Michael S and Miyamoto, David T and Maheswaran, Shyamala and Haber, Daniel A},
title = {DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs},
journal = {Cell},
year = {2023},
volume = {186},
number = {13},
pages = {2765--2782.e28},
doi = {10.1016/j.cell.2023.05.028}
}
EUVIMED